Reporting Season – CSL Limited
CSL (CSL) reported its full-year 2025 profit results, which came in with mixed results, with a stronger Plasma and Iron division offsetting weakness in the Vaccines division. The intention to spin out the vaccines business and a significant reduction in headcount [...]



